Development and validation of a stability-indicating method for the quantitation of paclitaxel in pharmaceutical dosage forms

Journal of Chromatographic Science

Volumn 47, Issue 7, 2009, Pages 599-604

  Mohammadi, Ali ^a,b   Esmaeili, Farnaz ^a   Dinarvand, Rasoul ^a   Atyabi, Fatemeh ^a   Walker, Roderick B ^c  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c RHODES UNIVERSITY   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 70350191631     PISSN: 00219665     EISSN: None     Source Type: Journal    
DOI: 10.1093/chromsci/47.7.599     Document Type: Article

References (29)

1. M.J. O'Neil, A. Smith, and P.E. Heckelman. The Merck Index, An Encyclopedia of Chemicals, Drugs and Biologicals, 14th ed. Merck & Co. Inc., White House Station, NJ, 2006, p. 1204.
2. S.C. Sweetman. Martindale the Complete Drug Reference, 35th ed. Pharmaceutical Press, London, UK, 2006, p. 685.
3. G.M. Zentner, R. Rathi, C. Shih, J.C. McRea, M. Seo, H. Oh, B.G. Rhee, J. Mestecky, Z. Moldoveanu, M. Morgan, and S. Weitman. Biodegradable block copolymers for delivery of pro- teins and water-insoluble drugs. J. Controlled Release 72: 203-215 (2001).
4. S.G. Arbuck and B. Blaylock. TAXOL: clinical results and current issues in development. In TAXOL: Science and Applications. M. Suffness, ed. CRC Press, New York, NY, 1995, p. 379.
5. G. Hempel, D. Lehmkuhl, S. Krumpelmann, G. Blaschke, and J. Boos. Determination of paclitaxel in biological fluids by micellar electrokinetic chromatography. J. Chromatogr. A 745: 173-179 (1996).
6. G. Theodoridis, G. Laskaris, E.L.M. van Rozendaal, and R. Ver- poorte. Analysis of taxines in Taxus plant material and cell cultures by HPLC photodiode array and HPLC-electrospray mass spectrometry. J. Liquid Chromatogr. Rel. Tech. 24: 2267-2282 (2001).
7. S.F. Baldrey, R.R. Brodie, G.R. Morris, E.H. Jenkins, and S.T. Brookes. Comparison of LC-UV and LC-MS-MS for the determination of taxol. Chromatographia 55: S187-S192 (2002).
8. A. Sparreboom, P. de Bruijn, K. Nooter, W.J. Loos, G. Stoter, and J. Verweij. Determination of paclitaxel in human plasma using single solvent extraction prior to isocratic reversed-phase high-performance liquid chromatography with ultraviolet detection. J. Chromatogr. B 705: 159-164 (1998).
9. S.H. Lee, S.D. Yoo, and K.H. Lee. Rapid and sensitive determination of paclitaxel in mouse plasma by high-performance liquid chromatography. J. Chromatogr. B 724: 357-363 (1999).
10. T. Nguyen, J. Eshraghi, G. Gonyea, R. Ream, and R. Smith. Studies on factors influencing stability and recovery of paclitaxel from sus- pension media and cultures of Taxus cuspidata cv Densiformis by high-performance liquid chromatography. J. Chromatogr. A 911: 55-61 (2001).
11. ®) in biological samples with application to preclinical pharmacokinetics and biodistribution. J. Pharm. Biomed. Anal. 39: 170-176 (2005).
12. H.Y. Aboul-Enein and V. Serignese. Liquid chromatographic determination of taxol and related derivatives using a new polyfluorinated reversed-phase column. Anal. Chim. Acta 319: 187-190 (1996).
13. I. Badea, D. Ciutaru, L. Lazar, D. Nicolescu, and A. Tudose. Rapid HPLC method for the determination of paclitaxel in phar- maceutical forms without separation. J. Pharm. Biomed. Anal. 34: 501-507 (2004).
14. ® EL from paclitaxel for quantitative analysis by HPLC-UV. J. Pharm. Biomed. Anal. 41: 117-123 (2006).
15. ® EL. J. Pharm. Biomed. Anal. 34: 493-499 (2004).
16. United States Pharmacopeia 29, National Formulary 24, U.S. Pharmacopeial Convention Inc., Rockville, 2006, pp.1624-1627.
17. ICH, Stability Testing of New Drug Substances and Products (Q1AR2). International Conference on Harmonization, IFPMA, Geneva, 2003.
18. U.D. Neue and J.R. Mazzeo. A theoretical study of the optimization of gradients at elevated temperature. J. Sep. Sci. 24: 921-929 (2001).
19. W. Dolan. The hazards of adjusting gradients. LC-GC 20: 940-946 (2002).
20. S. Williams. Ghost peaks in reversed-phase gradient HPLC: a review and update. J. Chromatogr. A 1052: 1-11 (2004).
21. H.F.M. Boelens, R.J. Dijkstra, P.H.C. Eilers, F. Fitzpatrick, and J.A. Westerhuis. New background correction method for liquid chromatography with diode array detection, infrared spectroscopic detection and Raman spectroscopic detection. J. Chromatogr. A 1057: 21-30 (2004).
22. A. Mohammadi, I. Haririan, N. Rezanour, L. Ghiasi, and R.B.Walker. A stability-indicating high performance liquid chromatographic assay for the determination of orlistat in capsules. J. Chromatogr. A 1116: 153-157 (2006).
23. A. Mohammadi, N. Rezanour, M. Ansari Dogaheh, F. Ghorbani Bidkorbeh, M. Hashem, and R.B. Walker. A stability-indicating high performance liquid chromatographic (HPLC) assay for the simultaneous determination of atorvastatin and amlodipine in commercial tablets. J. Chromatogr. B 846: 215-221(2007).
24. J.C. Miller and J.N. Miller. Statistics for Analytical Chemistry, vol. 22. Ellis Horwood, Chichester, UK, 1984. p. 82.
25. A. Mohammadi, A. Mehramizi, F. Aghaee Moghaddam, L. Erfani Jabarian, M. Pourfarzib, and H.N. Kashani. Development and validation of a stability-indicating high performance liquid chro- matographic (HPLC) assay for biperiden in bulk form and pharmaceutical dosage forms. J. Chromatogr. B 854: 152-157 (2007).
26. ICH Draft Guidelines on Validation of Analytical procedures: Definitions and Terminology, Federal Register, Vol. 60, IFPMA, Switzerland, 1995.
27. M. Zeaiter, J.M. Roger, V.B. Maurel, and D.N. Rutledge. Robustness of models developed by multivariate calibration. Part I: the assessment of robustness. Trends Anal. Chem. 23: 157-170 (2004).
28. M. Mulholland. Ruggedness testing in analytical chemistry. Trends Anal. Chem. 7: 383-389 (1988).
29. Y.V. Heyden, A. Nijhuis, J.S. Verbeke, B.G.M. Vandeginste, and D.L. Massaret. Guidance for robustness/ruggedness tests in method validation. J. Pharm. Biomed. Anal. 24: 723-753 (2001).